EFFICACY AND SAFETY OF INTRAMUSCULAR HALOPERIDOL AND OLANZAPINE IN MANAGEMENT OF ACUTELY AGITATED PATIENTS IN THE EMERGENCY DEPARTMENT: A RANDOMISED CONTROLLED TRIAL.

Department of emergency medicine All India Institute of Medical Sciences New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Males and females between age of 18 and 65 years presenting to emergency department with agitation.
•Agitation being defined as psychomotor agitation or violent behavior assessed with Altered Mental Status Scale (AMSS) score of 3 or more.

•1.Patients with age less than 18 years.
•2.Patients with age more than 65 years.
•3.Pregnant or breast-feeding patients.
•4.Known Hypersensitivity/allergy to given drugs.
•5.Patients having known extrapyramidal symptoms or parkinsonism.
•6.Individuals having pre-existing cardiovascular illness (CAD/ Previous h/o cardiac arrest/ sustained arrhythmias/ Family history of sudden cardiac death).
•7.Individuals having pre-existing respiratory illness (Asthma or COPD).
•8.Individuals with known pre-existing CVA or intracranial lesion.
•9.Individuals having seizure disorder.
•10.Individuals/LAR who fail to give valid consent.
•11.Patients with known QTc prolongation.

发起方

Department of emergency medicine All India Institute of Medical Sciences New Delhi